Indian Journal of Physical Medicine and Rehabilitation

Register      Login

VOLUME 26 , ISSUE 1 ( March, 2015 ) > List of Articles

RESEARCH ARTICLE

Grading of Adductor Spasticity in Cerebral Palsy – A New Approach

Vinay Goyal, Nonica Laisram

Citation Information : Goyal V, Laisram N. Grading of Adductor Spasticity in Cerebral Palsy – A New Approach. Indian J Phy Med Rehab 2015; 26 (1):2-5.

DOI: 10.5005/ijopmr-26-1-2

Published Online: 00-03-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Spastic cerebral palsy is the most common form of cerebral palsy. Spasticity in hip adductor causes discomfort, stiffness and difficulties in performing physical activities such as seating, transfers and walking. Grading of hip adductor spasticity is still a challenge in the field of rehabilitation. A simple method to assess hip adductor spasticity and use it as outcome measures of intervention is needed in general clinical practice.

We propose a visual method for grading hip adductor spasticity i.e grade 1= touch at ankle, grade 2 = crossing at ankle and grade 3 = crossing at knee in spastic cerebral palsy children. We followed 60 spastic cerebral palsy children over a period of three months on oral antispastic medication and found it very useful to assess response to drug. Intially hip adductor spasticity of grade 3 was observed in 10 %, grade 2- 8.33%, grade 1- 26.66% and 45% patients had no scissoring. After three months of drug therapy improvement was observed as grade 3 seen in 1 %, grade 2 - 7%, grade 1 - 23.33% and patients with no scissoring rose to 63.3%. These observations show that visual method for hip adductor spasticity is a simple and helpful method for grading response to therapeutic intervention.


PDF Share
  1. Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children. Rev Chir Orthop Reparatrice Appar Mot 2002; 88: 279-85.
  2. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study. Dev Med Child Neurol 2000;48:10-3.
  3. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 2006;48:64-73.
  4. Interrater reliability of a Modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.
  5. Oral pharmacotherapy of childhood movement Disorder. J Child Neurol 2003; 18: 40-9.
  6. A controlled trial of baclofen in children with cerebral palsy. J Int Med Res 1977;5:398-405.
  7. Oral baclofen in children with cerebral palsy: a double blind cross over pilot study. J Paediatr Child Health 2006; 42: 715-20.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.